ARIAD has initiated a phase I clinical trial of its Investigational Oral Multi-Targeted Kinase Inhibitor, AP24534 in Patients with Hematological Cancers
Filed under: kinase | Tagged: AP-24534, AP24534, Ariad, multikinase, phase I | Leave a Comment »
US and WO patent update for the week ending 05/23
Posted on May 22, 2008 by crimsoncanary
US and WO kinase patents have been updated for this week at KinaseCentral.com
Filed under: kinase | Tagged: kinase, patents | Leave a Comment »
Pfizer publish series of CDK4 inhibitors
Posted on May 22, 2008 by crimsoncanary
